image credit: Freepik

CDER Approved 55 Novel Drugs in 2023

January 18, 2024


FDA’s Center for Drug Evaluation and Research (CDER) published its New Drug Therapy Approvals 2023 report on Jan. 16, 2024 highlighting new drugs approved in 2023. CDER approved 55 novel drugs during the year and expanded indications or patient populations for previously approved products.

The approved drugs treat a variety of diseases including COVID-19, respiratory syncytial virus (RSV), HIV, neurological conditions, anemia, weight management, type 2 diabetes, and endocrine disorders. Drugs were also approved that treat opioid addiction, three of which were over-the-counter opioid overdose reversal drugs.

Read More on Biopharm International